These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3303848)

  • 21. [The hepatorenal syndrome].
    Møller S; Abrahamsen J; Ring-Larsen H; Henriksen JH
    Ugeskr Laeger; 1995 May; 157(22):3185-9. PubMed ID: 7770981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kidney involvement in infectious diseases].
    Bogomolov BP
    Ter Arkh; 1997; 69(6):70-2. PubMed ID: 9297283
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatorenal disorders: role of the renin-angiotensin-aldosterone system.
    Bernardi M; Trevisani F; Gasbarrini A; Gasbarrini G
    Semin Liver Dis; 1994 Feb; 14(1):23-34. PubMed ID: 8016659
    [No Abstract]   [Full Text] [Related]  

  • 24. Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function.
    Yarger WE; Schocken DD; Harris RH
    J Clin Invest; 1980 Feb; 65(2):400-12. PubMed ID: 7356687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in renal function and the intracellular environment in cirrhotic patients].
    Tiberio López G; Tanco S; Orradre B; Berrade MF; Anderiz López M
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):367-78. PubMed ID: 2988084
    [No Abstract]   [Full Text] [Related]  

  • 27. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S; Henriksen JH
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis and outcome of hepatorenal syndrome in patients undergoing orthotopic liver transplant.
    Gonwa TA; Poplawski S; Paulsen W; Brajtbord D; Goldstein R; Husberg B; Klintmalm GB
    Transplantation; 1989 Feb; 47(2):395-7. PubMed ID: 2645724
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatorenal syndrome].
    Ogura Y; Suzuki Y
    Nihon Rinsho; 1992 Jan; 50 Suppl():236-9. PubMed ID: 1578684
    [No Abstract]   [Full Text] [Related]  

  • 30. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 31. Respiratory support and renal function.
    Priebe HJ; Hedley-Whyte J
    Int Anesthesiol Clin; 1984; 22(1):203-26. PubMed ID: 6392111
    [No Abstract]   [Full Text] [Related]  

  • 32. [Update on hepatorenal syndrome].
    Blaise P; Moonen M; Rorive G
    Nephrologie; 2002; 23(1):11-7. PubMed ID: 11887572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New clues to the pathophysiology of hepatorenal failure.
    Lang F; Gerok W; Häussinger D
    Clin Investig; 1993 Feb; 71(2):93-7. PubMed ID: 8461632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal Function in Cirrhosis: A Critical Review of Available Tools.
    Piano S; Brocca A; Angeli P
    Semin Liver Dis; 2018 Aug; 38(3):230-241. PubMed ID: 30041275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal hemodynamic changes in heart failure.
    Blankstein R; Bakris GL
    Heart Fail Clin; 2008 Oct; 4(4):411-23. PubMed ID: 18760753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatorenal failure.
    Davison AM
    Nephrol Dial Transplant; 1996; 11 Suppl 8():24-31. PubMed ID: 9044337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal prostaglandins and the control of renal function in liver disease.
    Epstein M
    Am J Med; 1986 Jan; 80(1A):46-55. PubMed ID: 3511684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of ascites formation and hepatorenal syndrome: humoral and hemodynamic factors.
    Ring-Larsen H; Henriksen JH
    Semin Liver Dis; 1986 Nov; 6(4):341-52. PubMed ID: 3544227
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatorenal syndrome].
    Kürer I; Sommerer A; Puhl G; Kaisers U; Boemke W
    Anaesthesist; 2006 Jan; 55(1):95-107; quiz 108-9. PubMed ID: 16372167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.